Gilyazova, I.,
Ivanova, E.,
Pavlov, V.,
Khasanova, G.,
Khasanova, A.,
Izmailov, A.,
Asadullina, D.,
Gilyazova, G.,
Wang, G.,
Gareev, I.,
Beylerli, O. (2023) pathogenesis of HFRS is
required. Determination of the expression level of exosomal micro
RNAs (mi
RNAsGareev, Ilgiz,
Beylerli, Ozal,
Tamrazov, Rasim,
Ilyasova, Tatiana,
Shumadalova, Alina,
Du, Weijie,
Yang, Baofeng (2023) on microRNA (miRNA)-based therapy. Mi
RNAs possess the ability to function as suppressors of tumor growth
Beylerli, Ozal,
Encarnacion Ramirez, Manuel de Jesus,
Shumadalova, Alina,
Ilyasova, Tatiana,
Zemlyanskiy, Mikhail,
Beilerli, Aferin,
Montemurro, Nicola (2023) -free micro
RNAs (mi
RNAs), which remain stable and detectable in human bodily fluids, such as blood
Mukhametov, Ural,
Lyulin, Sergey,
Borzunov, Dmitry,
Ilyasova, Tatiana,
Gareev, Ilgiz,
Sufianov, Albert (2023) at the stages of surgical treatment (the nearest post-traumatic period and
long-term periods) in the absence
Ivanova, Elizaveta,
Asadullina, Dilara,
Gilyazova, Gulshat,
Rakhimov, Radmir,
Izmailov, Adel,
Pavlov, Valentin,
Khusnutdinova, Elza,
Gilyazova, Irina (2023) . Modern studies demonstrate the high potential of exosomal mi
RNAs as diagnostic
and prognostic markers
Guan, Xiaoxiang,
Zhang, Yiwei,
Gareev, Ilgiz,
Beylerli, Ozal,
Li, Xinyuan,
Lu, Guitian,
Lv, Lin,
Hai, Xin (2023) PTEN” [
Non-coding RNA Res. 6 (2021)146–152, (S2468054021000329), (10.1016/j.ncrna.2021.09.002)]